| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Masataka Nakamura, Yuko Iwasaki, Toshiyuki Takahashi, Kimihiko Kaneko, Ichiro Nakashima, Takenobu Kunieda, Satoshi Kaneko, Hirofumi Kusak. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Multiple sclerosis and related disorders. vol 17. 2018-06-07. PMID:29055448. |
myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis (on) and myelitis are recognized as important differential diagnosis of aquaporin-4 (aqp4) antibody-positive neuromyelitis optica (nmo)/nmo spectrum disorder (nmosd). |
2018-06-07 |
2023-08-13 |
Not clear |
| Takeshi Kezuka, Hitoshi Ishikaw. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Japanese journal of ophthalmology. vol 62. issue 2. 2018-04-23. PMID:29445944. |
anti-myelin-oligodendrocyte glycoprotein (mog) antibody positive optic neuritis has been established as a new subset of optic neuropathy. |
2018-04-23 |
2023-08-13 |
Not clear |
| Thashi Chang, Patrick Waters, Mark Woodhall, Angela Vincen. Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity. The neurologist. vol 22. issue 3. 2018-03-05. PMID:28471902. |
recurrent optic neuritis associated with mog antibody seropositivity. |
2018-03-05 |
2023-08-13 |
Not clear |
| R Deschamps, A Lecler, C Lamirel, J Aboab, A Gueguen, C Bensa, C Vignal, O Gou. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. European journal of neurology. vol 24. issue 6. 2018-02-12. PMID:28477397. |
new criteria for the diagnosis of multiple sclerosis (ms) and discovery of myelin oligodendrocyte glycoprotein (mog) or aquaporin-4 (aqp4) antibodies (abs) have changed the management of optic neuritis (on). |
2018-02-12 |
2023-08-13 |
Not clear |
| Matthias Baumann, Eva-Maria Hennes, Kathrin Schanda, Michael Karenfort, Barbara Kornek, Rainer Seidl, Katharina Diepold, Heinz Lauffer, Iris Marquardt, Jurgis Strautmanis, Steffen Syrbe, Silvia Vieker, Romana Höftberger, Markus Reindl, Kevin Rostás. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases. Multiple sclerosis (Houndmills, Basingstoke, England). vol 22. issue 14. 2018-01-26. PMID:26869530. |
myelin oligodendrocyte glycoprotein (mog) antibodies have been described in children with acute disseminated encephalomyelitis (adem), recurrent optic neuritis, neuromyelitis optica spectrum disorders and more recently in children with multiphasic disseminated encephalomyelitis (mdem). |
2018-01-26 |
2023-08-13 |
Not clear |
| Yuriko Azuchi, Atsuko Kimura, Xiaoli Guo, Goichi Akiyama, Takahiko Noro, Chikako Harada, Atsuko Nishigaki, Kazuhiko Namekata, Takayuki Harad. Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis. Neuroscience letters. vol 639. 2017-12-19. PMID:28040492. |
herein, we investigated the therapeutic potential of valproic acid (vpa) on optic neuritis in experimental autoimmune encephalomyelitis (eae), a mouse model of ms. eae was induced in c57bl/6 mice by immunization with mog |
2017-12-19 |
2023-08-13 |
mouse |
| Tetsuya Akaishi, Ichiro Nakashima, Takayuki Takeshita, Kimihiko Kaneko, Shunji Mugikura, Douglas Kazutoshi Sato, Toshiyuki Takahashi, Toru Nakazawa, Masashi Aoki, Kazuo Fujihar. Different etiologies and prognoses of optic neuritis in demyelinating diseases. Journal of neuroimmunology. vol 299. 2017-08-14. PMID:27725114. |
we compared the clinical features of optic neuritis (on) that are frequently observed in various central nervous system demyelinating diseases, including multiple sclerosis (ms), anti-aquaporin 4 (aqp4) antibody- and anti-myelin oligodendrocyte glycoprotein (mog) autoantibody-related diseases. |
2017-08-14 |
2023-08-13 |
Not clear |
| Hadas Stiebel-Kalish, Itay Lotan, Judith Brody, Gabriel Chodick, Omer Bialer, Romain Marignier, Michael Bach, Mark Andrew Hellman. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study. PloS one. vol 12. issue 1. 2017-08-10. PMID:28125740. |
optic neuritis (on) in patients with anti-myelin oligodendrocyte glycoprotein (mog)-igg antibodies has been associated with a better clinical outcome than anti-aquaporin 4 (aqp4)- igg on. |
2017-08-10 |
2023-08-13 |
Not clear |
| İpek Polat, Uluç Yiş, Pakize Karaoğlu, Muge Ayanoğlu, Tülay Öztürk, Handan Güleryüz, Semra Hız Kuru. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case. Pediatrics. vol 137. issue 5. 2017-05-31. PMID:27244783. |
however, persistent mog antibodies are considered as a predicting factor for multiple sclerosis, optic neuritis relapses, and incomplete recovery of adem. |
2017-05-31 |
2023-08-13 |
human |
| Yoshitsugu Nakamura, Hideto Nakajima, Hiroki Tani, Takafumi Hosokawa, Shimon Ishida, Fumiharu Kimura, Kimihiko Kaneko, Toshiyuki Takahashi, Ichiro Nakashim. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report. BMC neurology. vol 17. issue 1. 2017-05-16. PMID:28420330. |
anti-myelin oligodendrocyte glycoprotein (mog) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (adem), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. |
2017-05-16 |
2023-08-13 |
Not clear |
| Joachim Havla, T Kümpfel, R Schinner, M Spadaro, E Schuh, E Meinl, R Hohlfeld, O Outteryc. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Journal of neurology. vol 264. issue 1. 2017-04-10. PMID:27844165. |
myelin-oligodendrocyte-glycoprotein (mog) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. |
2017-04-10 |
2023-08-13 |
human |
| Tadashi Adachi, Kenichi Yasui, Toshiyuki Takahashi, Kazuo Fujihara, Yasuhiro Watanabe, Kenji Nakashim. Anti-myelin Oligodendrocyte Glycoprotein Antibodies in a Patient with Recurrent Optic Neuritis Involving the Cerebral White Matter and Brainstem. Internal medicine (Tokyo, Japan). vol 55. issue 10. 2017-03-28. PMID:27181546. |
we herein report a case of recurrent optic neuritis involving the cerebral white matter and brainstem in a patient positive for anti-myelin oligodendrocyte glycoprotein (mog) antibodies. |
2017-03-28 |
2023-08-13 |
Not clear |
| Soichiro Numa, Takashi Kasai, Takayuki Kondo, Yukie Kushimura, Ayaka Kimura, Hisashi Takahashi, Kanako Morita, Akihiro Tanaka, Yu-Ichi Noto, Tomoyuki Ohara, Masanori Nakagawa, Toshiki Mizun. An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals. Internal medicine (Tokyo, Japan). vol 55. issue 6. 2016-10-11. PMID:26984094. |
acute disseminated encephalomyelitis (adem) followed by optic neuritis (on) has been reported as a distinct phenotype associated with anti-myelin oligodendrocyte protein (mog) antibody. |
2016-10-11 |
2023-08-13 |
Not clear |
| Elena H Martinez-Lapiscina, Maria Sepulveda, Ruben Torres-Torres, Salut Alba-Arbalat, Sara Llufriu, Yolanda Blanco, Ana M Guerrero-Zamora, Nuria Sola-Valls, Santiago Ortiz-Perez, Pablo Villoslada, Bernardo Sanchez-Dalmau, Albert Sai. Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders. Therapeutic advances in neurological disorders. vol 9. issue 5. 2016-09-01. PMID:27582898. |
usefulness of optical coherence tomography to distinguish optic neuritis associated with aqp4 or mog in neuromyelitis optica spectrum disorders. |
2016-09-01 |
2023-08-13 |
Not clear |
| Sudarshini Ramanathan, Russell C Dale, Fabienne Brilo. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmunity reviews. vol 15. issue 4. 2016-08-15. PMID:26708342. |
there is now international consensus that anti-mog antibodies are important in both pediatric and adult demyelination, and the clinical association of mog antibody-associated demyelination has been refined to include acute disseminated encephalomyelitis, relapsing and bilateral optic neuritis, and transverse myelitis. |
2016-08-15 |
2023-08-13 |
human |
| Hideki Nakajima, Masakatsu Motomura, Keiko Tanaka, Azusa Fujikawa, Ruka Nakata, Yasuhiro Maeda, Tomoaki Shima, Akihiro Mukaino, Shunsuke Yoshimura, Teiichiro Miyazaki, Hirokazu Shiraishi, Atsushi Kawakami, Akira Tsujin. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis. BMJ open. vol 5. issue 4. 2016-01-05. PMID:25838512. |
to investigate the differences of clinical features, cerebrospinal fluid (csf), mri findings and response to steroid therapies between patients with optic neuritis (on) who have myelin oligodendrocyte glycoprotein (mog) antibodies and those who have seronegative on. |
2016-01-05 |
2023-08-13 |
Not clear |
| Rie S Tsuburaya, Naoki Miki, Keiko Tanaka, Takashi Kageyama, Kaori Irahara, Souichi Mukaida, Kazuhiro Shiraishi, Masami Tanak. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis. Brain & development. vol 37. issue 1. 2015-08-04. PMID:24582475. |
anti-myelin oligodendrocyte glycoprotein (mog) antibodies in a japanese boy with recurrent optic neuritis. |
2015-08-04 |
2023-08-12 |
Not clear |
| Akihiko Miyauchi, Yukifumi Monden, Meri Watanabe, Hideo Sugie, Mitsuya Morita, Takeshi Kezuka, Mariko Momoi, Takanori Yamagat. Persistent presence of the anti-myelin oligodendrocyte glycoprotein autoantibody in a pediatric case of acute disseminated encephalomyelitis followed by optic neuritis. Neuropediatrics. vol 45. issue 3. 2015-01-21. PMID:24610298. |
we report the case of a 5-year-old japanese girl who initially had acute disseminated encephalomyelitis (adem) and was positive for the myelin oligodendrocyte glycoprotein (mog) antibodies and developed unilateral optic neuritis (on) 71 days after adem onset. |
2015-01-21 |
2023-08-12 |
Not clear |
| Masami Tanaka, Keiko Tanak. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. Journal of neuroimmunology. vol 270. issue 1-2. 2014-06-05. PMID:24703097. |
here, sera samples from 48 consecutive japanese patients with myelitis or optic neuritis (on), but negative for anti-aquaporin (aqp) 4 antibodies (abs), and 14 anti-aqp4 ab-positive patients were tested for anti-mog abs using a cell-based immunofluorescence assay with full-length human mog cdna. |
2014-06-05 |
2023-08-13 |
human |
| Markus Reindl, Franziska Di Pauli, Kevin Rostásy, Thomas Berge. The spectrum of MOG autoantibody-associated demyelinating diseases. Nature reviews. Neurology. vol 9. issue 8. 2014-01-15. PMID:23797245. |
cell-based immunoassays using mog expressed in mammalian cells have demonstrated the presence of high-titre mog antibodies in paediatric patients with acute disseminated encephalomyelitis, ms, aquaporin-4-seronegative neuromyelitis optica, or isolated optic neuritis or transverse myelitis, but only rarely in adults with these disorders. |
2014-01-15 |
2023-08-12 |
human |